Skip to main content
Log in

Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Duodenogastric reflux has a deleterious effect on the gastric mucosa. It was the aim of this study to assess the acute effects of cisapride on antroduodenal motility and duodenogastric reflux in seven patients with severe dyspepsia and increased biliary reflux, as evidenced by increased bile salt output in their gastric aspirates. Each patient underwent two studies on separate days. On each day, after an overnight fast, each patient swallowed a multilumen tube for manometric recording of gastroduodenal motility. Phenol red was infused into the second portion of the duodenum, gastric juice was aspirated, and motor activity was monitored for 90 min. At the end of this period, the patient received either cisapride or placebo intravenously in a double-blind randomized fashion. Antroduodenal motility and duodenogastric reflux were monitored for the subsequent 90 min. A significantly (P<0.01) higher motility index was found in the antrum after cisapride (2678±712 vs 1110±412 in the basal period) while placebo had no effect. The duodenal motility index was not affected by cisapride or placebo. Bile salt outputs in gastric aspirates were significantly (P<0.05) reduced following cisapride injection (0.42±0.6 mmol vs 1.6±1.2 mmol during basal period). Conversely, outputs of phenol red in the gastric aspirates were unaffected by cisapride. In conclusion, cisapride stimulates antral motility and decreases biliary reflux in patients with dyspepsia and increased duodenogastric reflux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wormsley RG: Aspects of duodenogastric reflux in man. Gut 13:243–250, 1972

    PubMed  Google Scholar 

  2. Delaney JP, Cheng JW, Butler BA, Ritchie WP: Gastric ulcer and regurgitation gastritis. Gut 11:715–719, 1979

    Google Scholar 

  3. Lawson HH: Effect of duodenal contents on the gastric mucosa under experimental conditions. Lancet 1:469–472, 1964

    Google Scholar 

  4. Miranda M, Defilippi C, Valenzuela JE: Abnormalities of the interdigestive motility complex and increased duodenogastric reflux in gastric ulcer patients. Dig Dis Sci 30:16–21, 1985

    PubMed  Google Scholar 

  5. Tolin RD, Malmud LS, Stelzer F, Menin R, Makler PD, Applegate G, Fisher RS: Enterogastric reflux in normal subjects and patients with Billroth II gastroenterostomy. Gastroenterology 77:1027–1033, 1979

    PubMed  Google Scholar 

  6. Robbins PL, Broodie TA, Sosin H, Delaney JP: Reflux gastritis—the consequences of intestinal juice in the stomach. Am J Surg 131:23–29, 1976

    PubMed  Google Scholar 

  7. Rhods J, Barnardo DE, Phillips SF, Rovelstad RA, Hofmann AF: Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 57:241–252, 1969

    PubMed  Google Scholar 

  8. Thompson WG: Nonulcer dyspepsia. Can Med Assoc J 130:565–569, 1984

    PubMed  Google Scholar 

  9. Reyntjens A, Verlinden M, De Coster R, Janisch JD, Smout D, De Creg J, Leempaels J, Verhaegen MS: Clinical pharmacological evidence for cisapride's lack of antiadrenaline or direct cholinergic properties. Curr Ther Res 36:1045–1052, 1984

    Google Scholar 

  10. Reboa G, Arnulfo G, Di Somma C, Frascio M, Arzillo G, Berti-Riboli E, Lucchetti G: Prokinetic effects of cisapride on normal antroduodenal motility and reflexes. Curr Ther Res 36:18–23, 1984

    Google Scholar 

  11. Jian R, Ducrot F, Piedeloup C, Mary JY, Najean Y, Bernier JJ: Measurement of gastric emptying in dyspeptic patients: Effect of a new gastrokinetic agent (cisapride). Gut 26:352–358, 1985

    PubMed  Google Scholar 

  12. Edwards CA, Holden S, Brown C, Read NW: Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 28:13–16, 1987

    PubMed  Google Scholar 

  13. Dixon MF, O'Connor HJ, Axon ATR, King RFJG, Johnston D: Reflux gastritis: Distinct histopathological entity? J Clin Pathol 39:524–530, 1986

    PubMed  Google Scholar 

  14. Dooley CP, Reznick JB, Valenzuela JE: Variations in gastric and duodenal motility during gastric emptying of liquid meals in humans. Gastroenterology 87:1114–1119, 1984

    PubMed  Google Scholar 

  15. Pantoja JL, Defilippi C, Valenzuela JE, Csendes A: Nonsteroidal anti-inflammatory drugs: Effect on pyloric sphincter and duodenogastric reflux. Dig Dis Sci 24:217–220, 1979

    PubMed  Google Scholar 

  16. Talalay P: Analysis of steroid hormones. Methods Biochem Anal 8:119–143, 1960

    PubMed  Google Scholar 

  17. Muller-Lissner SA, Fimmel CJ, Sonnenberg A, Will N, Muller-Duysing W, Heinzel F, Blum AL: A novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcers. Gut 24:510–518, 1983

    PubMed  Google Scholar 

  18. Muller-Lissner SA, Frass C: Dissociation of duodenogastric marker reflux and bile salt reflux. Dig Dis Sci 30:733–738, 1985

    PubMed  Google Scholar 

  19. Keane FB, DiMagno EP, Malagelada JR: Duodenogastric reflux in humans: Its relationship to fasting antroduodenal motility and gastric, pancreatic and biliary secretion. Gastroenterolgy 81:726–731, 1981

    Google Scholar 

  20. Davenport HW: Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 54:175–181, 1968

    PubMed  Google Scholar 

  21. Capper WM, Buckler TJ, Kilby JV, Gibson MJ: Gallstones, gastric secretion and flatulent dyspepsia. Lancet 1:413–415, 1967

    PubMed  Google Scholar 

  22. Hordijk ML, VanRoon F, Silberbusch J: Domperidone decreases duodenogastric reflux in patients with chronic gastritis. Neth J Med 30:172–180, 1987

    PubMed  Google Scholar 

  23. Miller LJ, Malagelada JR, Longstreth GF, Co VLW: Dysfunction of the stomach with gastric ulceration. Dig Dis Sci 25:857–864, 1980

    PubMed  Google Scholar 

  24. Francois I, De Nutte N: Cisapride in the treatment of functional nonulcer dyspepsia. Digestion 34:151, 1986 (abstract)

    Google Scholar 

  25. Muller-Lissner SA, Frass C: Chronic oral treatment with cisapride decreases high bile salt reflux rates. Am J Gastroenterol 81:354–357, 1986

    PubMed  Google Scholar 

  26. Dooley CP, Mello WD, Valenzuela JE: Effects of aspirin and prostaglandin E2 on the interdigestive motility complex and duodenogastric reflux in man. Dig Dis Sci 30:513–521, 1985

    PubMed  Google Scholar 

  27. Defilippi C, Manari N, Gomez E: Relationship between antropyloric and intestinal motility and duodenogastric reflux in fasting dogs. Dig Dis Sci 32:171–176, 1987

    PubMed  Google Scholar 

  28. Fisher R, Cohen S: Physicological characteristics of the human pyloric sphincter. Gastroenterology 64:67–75, 1973

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported in part by a grant from Janssen Pharmaceutical Co. Dr. Rezende-Filho is from the Instituto de Gastroenterologia de Goiania, Goiania, Brazil, and was supported by a Brazilian Council of Scientific and Technological Development Scholarship. Dr. Di Lorenzo is from the University of Napoli, Napoli, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rezende-Filho, J., Di Lorenzo, C., Dooley, C.P. et al. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Digest Dis Sci 34, 1057–1062 (1989). https://doi.org/10.1007/BF01536374

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01536374

Key words

Navigation